Table 2.
Groups | Controls | Cytology | HPV |
---|---|---|---|
No. of eligible patients | 31,488 | 32,058 | 34,126 |
Assigned but not screened | NA | 6509 | 6934 |
Ca detected among assigned but not screened women | NA | 42 | 32 |
Stage IA | NA | 0/42 (0 %) | 2/32 (6.2%) |
Stage IB | NA | 5/42 (11.9%) | 6/32 (18.8%) |
Stage II+ | NA | 33/42 (78.6%) | 20/32 (62.5%) |
Stage unknown | NA | 4/42 (9.5%) | 4/32 (12.5%) |
Ca deaths among assigned but not screened women | NA | 27/42 (64.3%) | 22/32 (68.8%) |
Ca detected among controls | 118 | ||
Ca deaths among controls | 64 |